Selegiline Hcl
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01037 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 27 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | KG + DL |
| 2 | schizophrenia | KG + DL |
| 3 | congenital disorder of glycosylation with defective fucosylation | KG + DL |
| 4 | retinal dystrophy with or without extraocular anomalies | KG + DL |
| 5 | Charcot-Marie-Tooth disease, demyelinating, type 1G | KG + DL |
| 6 | atypical glycine encephalopathy | KG + DL |
| 7 | myopia X-linked | KG + DL |
| 8 | myopia 26, X-linked, female-limited | KG + DL |
| 9 | syndromic myopia | KG + DL |
| 10 | hydranencephaly (disease) | KG + DL |
| 11 | attention deficit-hyperactivity disorder | KG + DL |
| 12 | faciodigitogenital syndrome | KG + DL |
| 13 | PLA2G6-associated neurodegeneration | KG + DL |
| 14 | chondromyxoid fibroma | KG + DL |
| 15 | trichotillomania | KG + DL |
| 16 | transient tic disorder | KG + DL |
| 17 | mixed anxiety and depressive disorder | KG + DL |
| 18 | tic disorder | KG + DL |
| 19 | Rasmussen subacute encephalitis | KG + DL |
| 20 | communication disorder | KG + DL |
| 21 | benign paroxysmal torticollis of infancy | KG + DL |
| 22 | childhood apraxia of speech | KG + DL |
| 23 | developmental disorder of mental health | KG + DL |
| 24 | stereotypic movement disorder | KG + DL |
| 25 | fetal nicotine spectrum disorder | KG + DL |
| 26 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 27 | paralysis agitans, juvenile, of Hunt | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.